Anne George

Robinson Way
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.

Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer.

Journal: European urology

Published: August 06, 2023

Evaluation of transabdominal and transperineal ultrasound-derived prostate specific antigen (PSA) density and clinical utility compared to MRI prostate volumes: A feasibility study.

Evaluation of transabdominal and transperineal ultrasound-derived prostate specific antigen (PSA) density and clinical utility compared to MRI prostate volumes: A feasibility study.

Journal: PloS one

Published: March 08, 2022

Resolving the immune landscape of human prostate at a single-cell level in health and cancer.

Resolving the immune landscape of human prostate at a single-cell level in health and cancer.

Journal: Cell reports

Published: January 25, 2021

Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.

Discovery of PTN as a serum-based biomarker of pro-metastatic prostate cancer.

Journal: British journal of cancer

Published: September 15, 2020

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification.

Identification and Validation of Leucine-rich α-2-glycoprotein 1 as a Noninvasive Biomarker for Improved Precision in Prostate Cancer Risk Stratification.

Journal: European urology open science

Published: August 21, 2020

A novel split mode TFBAR device for quantitative measurements of prostate specific antigen in a small sample of whole blood.

A novel split mode TFBAR device for quantitative measurements of prostate specific antigen in a small sample of whole blood.

Journal: Nanoscale

Published: April 23, 2020

Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study.

Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study.

Journal: BMC medicine

Published: December 14, 2019

A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'.

A single mitochondrial DNA deletion accurately detects significant prostate cancer in men in the PSA 'grey zone'.

Journal: World journal of urology

Published: September 16, 2017

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.

Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel.

Journal: Endocrine-related cancer

Published: August 04, 2016

Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre.

Evolution and oncological outcomes of a contemporary radical prostatectomy practice in a UK regional tertiary referral centre.

Journal: BJU international

Published: April 29, 2016

Showing 1-10 of 10

Last Updated: 09/26/2026